UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (20060) 20060
Book Chapter (235) 235
Publication (46) 46
Dissertation (34) 34
Newspaper Article (34) 34
Magazine Article (31) 31
Conference Proceeding (24) 24
Web Resource (10) 10
Book / eBook (3) 3
Book Review (2) 2
Reference (2) 2
Streaming Video (2) 2
Trade Publication Article (2) 2
Newsletter (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
rituximab (17982) 17982
humans (14558) 14558
science & technology (13411) 13411
life sciences & biomedicine (13168) 13168
female (7553) 7553
male (7356) 7356
middle aged (6151) 6151
antibodies, monoclonal, murine-derived (5163) 5163
adult (5094) 5094
aged (4710) 4710
treatment outcome (4403) 4403
hematology (4067) 4067
antibodies, monoclonal - therapeutic use (3900) 3900
oncology (3715) 3715
antineoplastic combined chemotherapy protocols - therapeutic use (2994) 2994
antibodies, monoclonal, murine-derived - therapeutic use (2841) 2841
biological and medical sciences (2815) 2815
medical sciences (2790) 2790
lymphoma (2191) 2191
antineoplastic agents - therapeutic use (2175) 2175
rituximab - therapeutic use (2151) 2151
immunologic factors - therapeutic use (2052) 2052
aged, 80 and over (1837) 1837
rheumatology (1794) 1794
care and treatment (1728) 1728
chemotherapy (1718) 1718
patients (1712) 1712
retrospective studies (1698) 1698
antibodies, monoclonal - administration & dosage (1677) 1677
antibodies, monoclonal, murine-derived - administration & dosage (1667) 1667
cyclophosphamide - administration & dosage (1574) 1574
prognosis (1560) 1560
immunology (1531) 1531
abridged index medicus (1525) 1525
lymphomas (1484) 1484
antineoplastic agents (1482) 1482
immunosuppressive agents - therapeutic use (1481) 1481
cancer (1454) 1454
hematologic and hematopoietic diseases (1424) 1424
adolescent (1394) 1394
medicine & public health (1389) 1389
young adult (1373) 1373
lymphoma, large b-cell, diffuse - drug therapy (1349) 1349
transplantation (1339) 1339
immunotherapy (1337) 1337
remission induction (1287) 1287
antineoplastic combined chemotherapy protocols - administration & dosage (1257) 1257
rituximab - administration & dosage (1204) 1204
hemic and lymphatic diseases (1196) 1196
vincristine - administration & dosage (1192) 1192
cyclophosphamide (1185) 1185
rheumatoid arthritis (1181) 1181
recurrence (1167) 1167
monoclonal antibodies (1153) 1153
leukemias. malignant lymphomas. malignant reticulosis. myelofibrosis (1143) 1143
doxorubicin - administration & dosage (1119) 1119
drug therapy (1103) 1103
follow-up studies (1092) 1092
disease-free survival (1085) 1085
cyclophosphamide - therapeutic use (1080) 1080
animals (1065) 1065
general & internal medicine (1059) 1059
prednisone - administration & dosage (1036) 1036
medicine, general & internal (1023) 1023
antibodies, monoclonal - adverse effects (1012) 1012
risk factors (1006) 1006
lymphocytes b (980) 980
analysis (964) 964
antimitotic agents (950) 950
antirheumatic agents - therapeutic use (948) 948
antibodies, monoclonal, murine-derived - adverse effects (928) 928
pharmacology. drug treatments (927) 927
b-lymphocytes - immunology (915) 915
antigens, cd20 - immunology (882) 882
drug therapy, combination (875) 875
health aspects (869) 869
child (863) 863
lymphoma, b-cell - drug therapy (862) 862
immune system diseases (853) 853
antineoplastic combined chemotherapy protocols - adverse effects (841) 841
combined modality therapy (834) 834
research (828) 828
time factors (817) 817
arthritis, rheumatoid - drug therapy (804) 804
lymphoma, non-hodgkin - drug therapy (796) 796
leukemia, lymphocytic, chronic, b-cell - drug therapy (787) 787
clinical trials (763) 763
antineoplastic agents - administration & dosage (729) 729
pharmacology & pharmacy (728) 728
prednisone - therapeutic use (727) 727
immunoglobulins (725) 725
tumors (715) 715
biopsy (709) 709
antibodies (694) 694
neurosciences & neurology (681) 681
lymphoma, follicular - drug therapy (676) 676
pediatrics (667) 667
lymphoma, large b-cell, diffuse - pathology (658) 658
b-lymphocytes - drug effects (655) 655
drug administration schedule (655) 655
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (18575) 18575
Japanese (484) 484
French (480) 480
Spanish (350) 350
German (329) 329
Chinese (239) 239
Russian (160) 160
Polish (82) 82
Portuguese (82) 82
Korean (75) 75
Czech (69) 69
Italian (68) 68
Hungarian (44) 44
Turkish (22) 22
Danish (17) 17
Croatian (16) 16
Norwegian (11) 11
Dutch (10) 10
Hebrew (10) 10
Finnish (7) 7
Slovak (5) 5
Swedish (5) 5
Icelandic (3) 3
Serbian (3) 3
Indonesian (2) 2
Persian (2) 2
Romanian (2) 2
Slovenian (2) 2
Belarusian (1) 1
Bosnian (1) 1
Catalan (1) 1
Estonian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal der Deutschen Dermatologischen Gesellschaft, ISSN 1610-0379, 07/2017, Volume 15, Issue 7, p. 729
Journal Article
The New England journal of medicine, ISSN 0028-4793, 09/2018, Volume 379, Issue 10, pp. 934 - 947
Journal Article
Journal Article
Rheumatology (Oxford, England), ISSN 1462-0324, 04/2018, Volume 57, Issue suppl_3
Journal Article
Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], ISSN 1424-3903, 06/2019, Volume 19, pp. S50 - S50
Journal Article
Annals of the rheumatic diseases, ISSN 0003-4967, 08/2018, Volume 77, Issue 8, pp. 1143 - 1150
Journal Article
Annals of oncology, ISSN 0923-7534, 09/2018, Volume 29, Issue 9, pp. 1932 - 1938
relapsed/refractory NHL | phase Ib | venetoclax | bendamustine-rituximab | Salvage Therapy - adverse effects | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Rituximab - pharmacokinetics | Bendamustine Hydrochloride - adverse effects | Chemotherapy-Induced Febrile Neutropenia - etiology | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - pharmacokinetics | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Neoplasm Recurrence, Local - drug therapy | Male | Bendamustine Hydrochloride - pharmacokinetics | Lymphoma, Non-Hodgkin - pathology | Neoplasm Recurrence, Local - pathology | Bendamustine Hydrochloride - administration & dosage | Bridged Bicyclo Compounds, Heterocyclic - adverse effects | Aged, 80 and over | Adult | Female | Lymphoma, Non-Hodgkin - drug therapy | Rituximab - adverse effects | Chemotherapy-Induced Febrile Neutropenia - epidemiology | Drug Administration Schedule | Bridged Bicyclo Compounds, Heterocyclic - administration & dosage | Disease Progression | Sulfonamides - pharmacokinetics | Rituximab - administration & dosage | Maximum Tolerated Dose | Progression-Free Survival | Sulfonamides - adverse effects | Aged | Lymphoma, Non-Hodgkin - mortality | Salvage Therapy - methods | Sulfonamides - administration & dosage | Bridged Bicyclo Compounds, Heterocyclic - pharmacokinetics | Drug Resistance, Neoplasm - drug effects | Index Medicus | relapsed | refractory NHL | Original | bendamustine–rituximab
Journal Article
British journal of haematology, ISSN 0007-1048, 11/2017, Volume 179, Issue 3, pp. 410 - 420
diffuse large B‐cell lymphoma | rituximab dose | sex | rituximab pharmacokinetics | diffuse large B-cell lymphoma | Life Sciences & Biomedicine | Hematology | Science & Technology | Doxorubicin - blood | Doxorubicin - therapeutic use | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Prognosis | Antineoplastic Combined Chemotherapy Protocols - blood | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Rituximab - blood | Vincristine - blood | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Dose-Response Relationship, Drug | Aged, 80 and over | Vincristine - administration & dosage | Female | Doxorubicin - administration & dosage | Rituximab - adverse effects | Prednisone - administration & dosage | Lymphoma, Large B-Cell, Diffuse - drug therapy | Prednisone - adverse effects | Drug Administration Schedule | Lymphoma, Large B-Cell, Diffuse - pathology | Treatment Outcome | Prednisone - blood | Rituximab - administration & dosage | Cyclophosphamide - blood | Medication Adherence | Lymphoma, Large B-Cell, Diffuse - blood | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Sex Factors | Survival Analysis | Vincristine - therapeutic use | Vincristine - adverse effects | Aged | Neoplasm Staging | Doxorubicin - adverse effects | Prednisone - therapeutic use | Aged patients | Care and treatment | Anthracyclines | Lymphomas | Corticosteroids | Analysis | Drugs | Toxicity | Sex | Males | Doxorubicin | Optimization | Risk factors | Older people | Rituximab | Pharmacology | Prednisone | Risk analysis | Survival | Patients | Vincristine | Lymphoma | Serum levels | Cyclophosphamide | Lymphocytes B | Medical prognosis | Females | Pharmacokinetics | Geriatrics | B-cell lymphoma | Index Medicus
Journal Article